tetano
Editor, Senior Moderator
Orbit
. 2021 Jan 5;1-4.
doi: 10.1080/01676830.2020.1867193. Online ahead of print.
Acute dacryoadenitis in a patient with SARS-CoV-2 infection
M?nica Mart?nez D?az[SUP] 1 [/SUP], Sergio Copete Piqueras[SUP] 1 [/SUP], Cristina Blanco Marchite[SUP] 1 [/SUP], Kaveh Vahdani[SUP] 2 [/SUP]
Affiliations
Abstract
We describe a retrospective case report of dacryoadenitis associated with orbital inflammatory disease in a patient with confirmed SARS-CoV-2 infection. A 22-year-old previously fit and healthy male presented with 4-day history of right ocular redness, eyelid swelling and blurred vision associated with discomfort and pain in the lacrimal gland area. He was found to have right acute dacryoadenitis based on clinical examination and orbital imaging. One day after initiation of oral antibiotic and non-steroidal anti-inflammatory therapy, he developed worsening of the orbital inflammation and partial ophthalmoplegia. Oral steroids were commenced resulting in rapid resolution of symptoms within a few days and clinical stability at 2 months. The patient did not have any systemic features of COVID-19 but he was in close contact with his mother and with his partner who both had respiratory symptoms and tested positive for SARS-CoV-2 antigen (PCR testing) 4 weeks prior. PCR testing from nasopharyngeal swab was negative for SARS-CoV-2 RNA; however, the serological test was positive for IgM/IgG SARS-CoV-2 antibodies. Extensive laboratory workup including infectious and autoimmune screening and chest x-ray were unremarkable. Orbital inflammatory disease due to infectious process or immunological response may potentially occur in COVID-19 patients, although the causal relationship remains uncertain.
Keywords: COVID-19; Coronavirus; dacryoadenitis; lid oedema; orbital inflammation; viral etiology.
. 2021 Jan 5;1-4.
doi: 10.1080/01676830.2020.1867193. Online ahead of print.
Acute dacryoadenitis in a patient with SARS-CoV-2 infection
M?nica Mart?nez D?az[SUP] 1 [/SUP], Sergio Copete Piqueras[SUP] 1 [/SUP], Cristina Blanco Marchite[SUP] 1 [/SUP], Kaveh Vahdani[SUP] 2 [/SUP]
Affiliations
- PMID: 33402004
- DOI: 10.1080/01676830.2020.1867193
Abstract
We describe a retrospective case report of dacryoadenitis associated with orbital inflammatory disease in a patient with confirmed SARS-CoV-2 infection. A 22-year-old previously fit and healthy male presented with 4-day history of right ocular redness, eyelid swelling and blurred vision associated with discomfort and pain in the lacrimal gland area. He was found to have right acute dacryoadenitis based on clinical examination and orbital imaging. One day after initiation of oral antibiotic and non-steroidal anti-inflammatory therapy, he developed worsening of the orbital inflammation and partial ophthalmoplegia. Oral steroids were commenced resulting in rapid resolution of symptoms within a few days and clinical stability at 2 months. The patient did not have any systemic features of COVID-19 but he was in close contact with his mother and with his partner who both had respiratory symptoms and tested positive for SARS-CoV-2 antigen (PCR testing) 4 weeks prior. PCR testing from nasopharyngeal swab was negative for SARS-CoV-2 RNA; however, the serological test was positive for IgM/IgG SARS-CoV-2 antibodies. Extensive laboratory workup including infectious and autoimmune screening and chest x-ray were unremarkable. Orbital inflammatory disease due to infectious process or immunological response may potentially occur in COVID-19 patients, although the causal relationship remains uncertain.
Keywords: COVID-19; Coronavirus; dacryoadenitis; lid oedema; orbital inflammation; viral etiology.